NFKB1 and breast carcinoma: By suppressing NF-κB activation, glaucine decreases the production of the MMP-9 gene, thereby limiting the migration and invasion of breast cancer cells (73) and modulating the immune response, primarily by reducing pro-inflammatory cytokine production and influencing intracellular signaling pathways in immune cells (74, 75).